Bell Investment Advisors, Inc Astrazeneca PLC Transaction History
Bell Investment Advisors, Inc
- $538 Million
- Q1 2025
A detailed history of Bell Investment Advisors, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 180 shares of AZN stock, worth $12,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 132
36.36%
Holding current value
$12,686
Previous $8,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,435Shares Held
507MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.87 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.21 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...